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New Delhi, India; and Dublin, IrelandCigarette smoking is the biggest killer of people
worldwide. Half of the 1 billion projected smokers
will die prematurely by the turn of this century if
they do not give up smoking [1]. Of those prema-
ture deaths, 70–80% could occur in low- and mid-
dle-income countries [1]. At the same time,
noncigarette smoking habits, including both the
use of bidis and electronic cigarettes, are growing
‘‘social norms’’ in the West and in the low- and
middle-income countries.
Bidis are small hand-rolled cigarettes made of a
small amount of sun-dried, flaked tobacco wrapped
in dried temburni or tendu leaf and tied with a string;
they are primarily produced and popular in India
and other South Asian countries [2]. ‘‘E-cigarettes’’
or electronic nicotine delivery system (ENDS) look
like cigarettes but do not contain or burn tobacco.
Instead, they refer to battery-powered atomizers
producing a vapor for inhalation from disposable
cartridges containing humectants such as propylene
glycol, flavors, and nicotine [3].E P I D EM IO LOG I CA L PA T T E RN S
Even though understanding about the epidemiol-
ogy of bidi use is improving, knowledge about the
use of e-cigarettes is grossly inadequate and
inconclusive. The Global Adult Tobacco Survey
India––one of the largest tobacco-use surveys
cosponsored by the Government of India––indi-
cated that more than one-third (35%) of adults in
India use tobacco [4]. Of all the prevalent smoking
forms of tobacco, bidi is the most popular product
in India. About 9% of Indian adults smoke bidis,
with use relatively more common in the rural areasFrom the Public Health Foundation of India, New Delhi, India; Tobac
(zkabir@tri.ie).both in India and Bangladesh [4,5]. It is interesting
to note that e-cigarettes were first patented in Chi-
na in 2007, and a recent survey in the United States
shows that almost 1 million Americans have ever
used e-cigarettes and the rate has quadrupled in re-
cent years [6]. Such a growing popularity of
products that are of unknown safety claims is a
wake-up call for the tobacco-control community
worldwide.
A very small fraction of bidis is produced for U.S.
markets. During the late 1990s, a growing appeal of
the bidi was observed among young people to whom
it was promoted as herbal bidi available in exciting
flavors [7]. The user profile, reasons for use, and mar-
keting strategies are very different in the United
States compared with South Asia. An earliest conve-
nience sample of 642 adolescents in Massachusetts
during 1999 found that 40% had smoked bidis at
least once during their lifetimes and 16% were cur-
rent users. Highest use was noted among Hispanic
students [7]. A significant increase in bidi use was re-
ported among Hispanic students between 2002 and
2004 [8]. More recent survey data collected in 2009
has indicated current use by 1.6% and 2.4% of mid-
dle-school and high-school students, respectively
(with any tobacco product use by 8.2% and 23.9%,
respectively). Gender difference is less marked in
the United States (where 2.1% of female and 2.7%
of male high-school students report current use) than
in South Asia, where use among women is very low
[9]. Urban students are more likely to smoke bidis
than suburban and rural students are [10]. In the
United States, two-thirds of adult bidi users are
under 25 years old. This reflects experimentation
among adolescents and has raised questions on the
possible role of bidis as ‘‘gateway’’ products to regularcoFree Research Institute, Dublin, Ireland. Correspondence: Z. Kabir
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bidis more addictive and, being cheaper, also aug-
ments the initiation of tobacco addiction.
Another area of increasing concern is the grad-
ual takeoff of bidi smoking among adolescents. A
bicentric study in Delhi and Chennai has shown
that Indian children in sixth grade may be using to-
bacco at higher rates than those in eighth grade––
thus strongly signaling that more and more young
youths are taking to this addictive behavior [12].
Current bidi-smoking prevalence among Indian
youths in grades 8–10 in the Global Youth
Tobacco Survey (2000–2004) was 2.3% in 26 states
of India and increased to 3.5% in 2006 (2006) in 30
states. Bidi smoking was nearly 4· higher among
boys (5.1%) than girls (1.3%) nationwide [2,13].HEA L TH E F F E C T S
Adverse effects of tobacco use on human health are
well established [14]. Compared with cigarettes,
bidis have much less tobacco but content can vary
from 0.15 g to 0.25 g [2]. Bidis sold in India and
other South Asian markets are mostly unflavored
and without a filter. In the United States and other
Western markets, they tend to be flavored in vari-
eties such as vanilla, strawberry, orange, and lime
and can be provided with a filter. Such marketing
strategies remind us of ‘‘candy’’ flavored cigarettes,
which were banned not so long in the United
States, and a similar legislation for menthol ciga-
rettes is certainly looming large. Bidis have been
found to produce approximately 3· the amount
of carbon monoxide and contain approximately
3· the amount of nicotine and approximately 5·
the amount of tar than cigarettes [15].
Similar to cigarette use, bidi use has been shown
to cause cardiovascular diseases, oral cancers, lung
cancers, and other health problems [2]. The large
case–control INTERHEART (A Study of Risk
Factors for First Myocardial Infarction in 52
Countries and Over 27,000 Subjects) study [16] as-
sessed the risk of acute myocardial infarction in 52
countries and reported that bidi use was signifi-
cantly associated with acute myocardial infarction
(odds ratios [OR]: 2.89, 95% confidence interval
[CI]: 2.11–3.96) compared with nonusers of any
tobacco products and also clearly showing a dose–
response relationship. Rastogi et al. [17] showed
a dose–response relationship of similar magnitude
for acute myocardial infarction among both bidi
and cigarette smokers compared with never smok-
ers. In a large cohort study from Mumbai, India,incident oral cancer in bidi smokers (relative risk
[RR]: 3.55; 95% CI: 2.40–5.24) was 42% higher
than in cigarette smokers (RR: 2.50; 95% CI:
1.65–3.78) [18]. A meta-analysis by Rahman
et al. [19] found statistically significant OR of 3.1
for risk of oral cancer for bidi smokers as compared
with never smokers. Bidi use has contributed to In-
dia having the dubious distinction of being the oral
cancer ‘‘capital’’ of the world. Bidi use has also
shown to be associated with a greater risk of devel-
oping tuberculosis [20].
E-cigarettes have no documented evidence of
the quantity of ‘‘free nicotine’’ delivered from such
devices. Limited evidence regarding adverse health
effects of electronic cigarettes is available to date
[21,22]. Testing of such products is also not qual-
ity-controlled or well reported. Varying levels of
nicotine are reported, even in products sold under
the same label [23]. A recent study demonstrated
that cotinine levels in ENDS users were similar
to the levels observed in cigarette smokers but
higher than those usually observed in nicotine
replacement therapy users [24].PUB L I C H EA L TH PO L I C Y OP T I ON S
Over the past 20 years, tobacco control has seen
successful developments mainly driven by robust
science coupled with strong public health advocacy,
such as indoor smoking restriction, advertising
bans, taxation, and education. Such developments
should provide opportunities to exert considerable
influence on controlling noncigarette smoking
products in ways that benefit public health. The
most successful of such developments, however, is
the introduction of the first international public
health treaty––the WHO Framework Convention
on Tobacco Control (FCTC)––in 2003. The
FCTC, although aiming for reducing health
effects of all forms of tobacco products through pol-
icy interventions, has largely focused on the effects
and regulation of cigarette smoking. This is partic-
ularly problematic in populations where manufac-
tured cigarettes do not dominate, such as India.
Article 8 of the FCTC recommends 100% bans
in worksites, restaurants, and bars. Bidis are mainly
consumed in open market places or inside homes or
small roadside coffee shops. Enforcement of a 100%
smoke-free policy under such circumstances must be
a herculean task. The next best alternative should be
strong health warnings, preferably pictorial health
warnings, as recommended in Article 11 of the
FCTC. Evidence has consistently shown that picto-
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knowledge of specific health effects of smoking in
a number of countries [25]. Nevertheless, very few
European and Western countries have adopted pic-
torial health warnings on cigarette packs to date. A
study conducted in India [26] reported bidi prod-
ucts were not compliant with packaging and label-
ing rules specified by the Cigarettes and Other
Tobacco Products (Prohibition of Advertising,
Regulation of Trade, Commerce, Supply, and Dis-
tribution) Act, 2003. This highlights the need for
more stringent implementation of the Cigarettes
and Other Tobacco Products Act’s guidelines to
combat the ever-growing tobacco menace.
Articles 9 and 10 of the FCTC deal with tobacco
product regulations. Even though the United States
has not ratified FCTC, the regulatory authority
provided to the U.S. Food and Drug Administra-
tion (FDA) in 2009 provides a mechanism to
achieve some of the same ends and may help create
precedents for other countries in terms of tobacco
product regulation. However, the prospects for reg-
ulating products, such as bidis, are less clear. Data
on the characteristics of noncigarette smoked prod-
ucts are sparse, and so further research is necessary
before implementing regulation of such tobacco
products. However, decentralized production and
cottage industries such as bidi making (rolling of bi-
dis mostly occur inside homes) may prove hurdles to
the full implementation of such regulations. Bidi
making is largely a family run livelihood involving
children, particularly in India. The Indian govern-
ment has developed legislation and policies aimed
at monitoring working conditions and providing
social security benefits for the welfare of bidi labor-
ers. However, the reality is policies and legislation
has done little to improve the working conditions
and livelihoods of bidi workers in India. Worker
protection is severely limited by the fragmented
nature of the bidi industry.
Taxation is the single most cost-effective anti-
smoking preventive tool. The pricing policies are
also affected by the affordability of the product: that
is, its ‘‘real price’’ in the context of income growth
and inflation [27]. Taxes can vary significantly for
noncigarette tobacco products. In India, cigarettes
are taxed at a rate over 60· higher than that for bi-
dis. Taxes on bidis should be increased to narrow
the price difference between cigarettes and bidis.
In India, the current taxation system on bidis allows
the industry to avoid paying taxes, as manufacturers
producing less than 2 million bidis a year are ex-
empt from excise duties. To evade taxes, large fac-tory owners fragment production into home-based
units to maximize their profits. There are three
main concerns or misconceptions regarding increas-
ing taxes on tobacco products in general: (1) a loss
to the state exchequer; (2) cross-border trading;
and (3) substitution for cheaper and more harmful
tobacco products. An economic analysis has found
that raising the excise duty on bidis to a point where
their price equals that of the lowest-priced ciga-
rettes would not reduce excise revenue, but would
help curb tobacco use [28].
Tobacco use is a health developmental issue
[29]. Therefore, implementation of poverty eradi-
cation programs by governmental agencies can be
an immediate alternative solution for bidi workers.
In India, health developmental programs such as
the Integrated Child Development Scheme and
the Sarva Siksha Abhiyan programs can be imple-
mented in bidi-rolling areas to encourage bidi
workers to send their children to schools. In India,
there should be immediate enforcement of the
provisions under the Bidi and Cigar Workers
(Condition of Employment) Act, 1966; Bonded
Labour System (Abolition Act), 1976; Child
Labour Act, 1986; Bidi Workers Welfare Fund
Act, 1976; and the Bidi Welfare Cess Act, 1976,
to improve the overall working conditions of the
bidi workers and give them their rightful benefits.
Creation of alternative livelihoods for workers con-
nected with the bidi industry is another necessary
policy for the sake of justice and human rights
and is required by the FCTC. Bidi workers can
also be linked to vocational training institutes
according to local market needs.
In contrast to bidi assembly, which is mainly an
unorganized sector, ENDS companies are sophisti-
cated and better organized. The e-cigarette social
community popularly known as ‘‘vapers,’’ is a fast-
growing online phenomenon [30]. The U.S.
FDA in April 2011 announced the intention of
regulating e-cigarettes as tobacco products only
when the FDA failed to regulate them as drug-
delivery devices in its initial attempt [31]. How-
ever, the tobacco companies have yet to make any
‘‘therapeutic’’ claims of electronic cigarettes. Evi-
dence of both safety and cessation benefits are lack-
ing, and, therefore, ENDS may become ‘‘bridge
products’’ [31] for use in places where smoking is
prohibited, including aircrafts, or as attractive star-
ter products for former and never smokers. Over
the past 5 years, there has been exponential expan-
sion of interest in tobacco harm reduction [32]. No
one knows exactly what long-term benefits/harms
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of bidis are well established. But, we all know the
truth: Abstinence is the best policy.CONC LU S I ON S
Noncigarette smoking products are widely avail-
able; their use varies nationally and regionally;
and they are popular despite the fact that they, in
the case of bidis, are equally hazardous as
cigarettes. A market is also emerging for nicotinedelivery systems not directly dependent on tobacco
(e.g., ENDS). The full implementation of FCTC,
with a special focus on noncigarette tobacco prod-
ucts, along with a leadership role of the U.S. FDA
may herald a new era for controlling noncigarette
smoking products.
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